Publications by authors named "S Pirotton"

Claim this Profile
I
Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial.
Hanisah Sharif, Iesha Singh, Lubna Kouser, Ralph Mösges, Marie-Alix Bonny, Sabine Pirotton

J Allergy Clin Immunol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trial.
R Mösges, C Bachert, P Panzner, M A Calderon, L Haazen, S Pirotton

Allergy· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients.
R Mösges, A F Koch, E Raskopf, J Singh, K Shah-Hosseini, S Pirotton

Allergy· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy.
R Mösges, E M Kasche, E Raskopf, J Singh, L Sohlich, S Pirotton

Allergy· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lolium perenne peptides for treatment of grass pollen allergy: A randomized, double-blind, placebo-controlled clinical trial.
Mohamed H Shamji, Jan Ceuppens, Claus Bachert, Peter Hellings, Gaël Placier, Sabine Pirotton

J Allergy Clin Immunol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis